KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2016 - 2024)

Historic Other Non-Current Liabilities for Pacific Biosciences Of California (PACB) over the last 15 years, with Q4 2024 value amounting to $18.7 million.

  • Pacific Biosciences Of California's Other Non-Current Liabilities fell 434.78% to $18.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $18.7 million, marking a year-over-year decrease of 434.78%. This contributed to the annual value of $18.7 million for FY2024, which is 434.78% down from last year.
  • Per Pacific Biosciences Of California's latest filing, its Other Non-Current Liabilities stood at $18.7 million for Q4 2024, which was down 434.78% from $20.6 million recorded in Q3 2024.
  • Over the past 5 years, Pacific Biosciences Of California's Other Non-Current Liabilities peaked at $186.3 million during Q2 2023, and registered a low of $752000.0 during Q4 2020.
  • Its 5-year average for Other Non-Current Liabilities is $78.1 million, with a median of $19.6 million in 2023.
  • Per our database at Business Quant, Pacific Biosciences Of California's Other Non-Current Liabilities soared by 2246875.0% in 2021 and then plummeted by 9923.4% in 2022.
  • Pacific Biosciences Of California's Other Non-Current Liabilities (Quarter) stood at $752000.0 in 2020, then surged by 22468.75% to $169.7 million in 2021, then crashed by 99.23% to $1.3 million in 2022, then surged by 1403.85% to $19.6 million in 2023, then decreased by 4.35% to $18.7 million in 2024.
  • Its Other Non-Current Liabilities was $18.7 million in Q4 2024, compared to $20.6 million in Q3 2024 and $19.5 million in Q2 2024.